EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MMFSyn: A Multimodal Deep Learning Model for Predicting Anticancer Synergistic Drug Combination Effect

Tao Yang, Haohao Li, Yanlei Kang, Zhong Li iD

Biomolecules · 2024

DOI: 10.3390/biom14081039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Tao Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Information Engineering, Huzhou University, Huzhou 313000, China. Hauptthemen laut MEDLINE: Deep Learning, Drug Synergism. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Plan Project of Huzhou City, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combination therapy aims to synergistically enhance efficacy or reduce toxic side effects and has widely been used in clinical practice. However, with the rapid increase in the types of drug combinations, identifying the synergistic relationships between drugs remains a highly challenging task. This paper proposes a novel deep learning model MMFSyn based on multimodal drug data combined with cell line features. Firstly, to ensure the full expression of drug molecular features, multiple modalities of drugs, including Morgan fingerprints, atom sequences, molecular diagrams, and atomic point cloud data, are extracted using SMILES. Secondly, for different modal data, a Bi-LSTM, gMLP, multi-head attention mechanism, and multi-scale GCNs are comprehensively applied to extract the drug feature. Then, it selects appropriate omics features from gene expression and mutation omics data of cancer cell lines to construct cancer cell line features. Finally, these features are combined to predict the synergistic anti-cancer drug combination effect. The experimental results verify that MMFSyn has significant advantages in performance compared to other popular methods, with a root mean square error of 13.33 and a Pearson correlation coefficient of 0.81, which indicates that MMFSyn can better capture the complex relationship between multimodal drug combinations and omics data, thereby improving the synergistic drug combination prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningDrug SynergismHumansCell Line, TumorAntineoplastic AgentsNeoplasmsAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

SMILESdeep learningmultimodal datasynergistic drug combination

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Information Engineering, Huzhou University, Huzhou 313000, China.
  • College of Science, Zhejiang Sci-Tech University, Hangzhou 310018, China.

ORCID-Profile: Zhong Li

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Plan Project of Huzhou City, China

Zitieren

APA

Yang, T., Li, H., Kang, Y., & Li, Z. (2024). MMFSyn: A Multimodal Deep Learning Model for Predicting Anticancer Synergistic Drug Combination Effect. Biomolecules. https://doi.org/10.3390/biom14081039

Vancouver

Yang T, Li H, Kang Y, Li Z. MMFSyn: A Multimodal Deep Learning Model for Predicting Anticancer Synergistic Drug Combination Effect. Biomolecules. 2024. doi:10.3390/biom14081039

BibTeX
@article{Yang2024,
  author = {Yang, Tao and Li, Haohao and Kang, Yanlei and Li, Zhong},
  title = {MMFSyn: A Multimodal Deep Learning Model for Predicting Anticancer Synergistic Drug Combination Effect},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14081039}
}
Kostenlos starten →